Gastroenterology Learning Network cover image

Progress in PBC: Seladelpar in Trial as Second-Line Therapy

Gastroenterology Learning Network

00:00

Addressing Symptoms in PBC with Seladelpar

This chapter discusses the importance of addressing symptoms in patients with PBC and how the drug Seladelpar may help improve symptoms such as itching, fatigue, abdominal discomfort, and poor sleep. It also highlights ongoing research on the association between Seladelpar efficacy and the cytokine IL-31.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app